Analysis of SAT Type Foot-And-Mouth Disease Virus Capsid Proteins and the Identification of Putative Amino Acid Residues Affecting Virus Stability

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Maree, Francois F ^a,b   Blignaut, Belinda ^a,b   de Beer, Tjaart A P ^b,c   Rieder, Elizabeth ^d  

^a ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^d PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; BUFFER; CAPSID PROTEIN; HISTIDINE; PHENYLALANINE; PROTEIN SAT2; PROTEIN SAT3; PROTEIN VP3; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; CHIMERA; FOOT AND MOUTH DISEASE VIRUS; HIGH TEMPERATURE; IONIC STRENGTH; NONHUMAN; PH MEASUREMENT; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTON TRANSPORT; SEROTYPE; VIRUS PARTICLE;

AMINO ACIDS; ANIMALS; CAPSID; CAPSID PROTEINS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; CRICETINAE; FOOT-AND-MOUTH DISEASE VIRUS; HYDROGEN-ION CONCENTRATION; MOLECULAR DYNAMICS SIMULATION; OSMOLAR CONCENTRATION; TEMPERATURE; VIRION;

EID: 84878071509     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061612     Document Type: Article

References (58)

1. Doel TR, Baccarini PJ, (1981) Thermal stability of foot-and-mouth disease virus. Arch Virol 70: 21-32.
2. Barnett PV, Carabin H, (2002) A review of emergency foot-and-mouth disease (FMD) vaccines. Vaccine 20: 1505-14.
3. Doel TR, (2003) FMD vaccines. Virus Res 91: 81-99.
4. Pay TWF, Rweyemamu MM, O'Reilly KJ (1978) Experiences with Type SAT 2 foot-and-mouth disease vaccines in Southern Africa. XVth Conference of the Office International Des Epizzoties Permanent Commision on foot-and-mouth disease. p1-25.
5. Preston KJ, Owens H, Mowat GN, (1982) Sources of variations encountered during the selection and production of three strains of FMD virus for the development of vaccine for use in Nigeria. J Biol Stand 10: 35-45.
6. Amadori M, Berneri C, Archetti IL, (1994) Immunogenicity of foot-and-mouth disease virus grown in BHK-21 suspension cells. Correlation with cell ploidy alterations and abnormal expression of the alpha 5 beta 1 integrin. Vaccine 12: 159-166.
7. Bachrach HL, (1968) Foot-and-mouth disease. Annu Rev Microbiol 22: 201-244.
8. Pereira HG, (1978) Antigenic variation in relation to epidemiology and control of foot and mouth disease. Br Vet J 35: 167-74.
9. Sobrino F, Saiz M, Jiménez-Clavero MA, Núñez JI, Rosas MF, et al. (2001) Foot-and-mouth disease virus: a long known virus, but a current threat. Vet Res 32: 1-30.
10. Domingo E, Baranowski E, Escarmís C, Sobrino F, (2002) Foot-and-mouth disease virus. Comp Immunol Microbiol Infect Dis 25: 297-308.
11. Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F, (1989) The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature 337: 709-716.
12. Curry S, Fry E, Blakemore W, Abu-Ghazaleh R, Jackson T, et al. (1996) Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Structure 4: 135-145.
13. Ellard FM, Drew J, Blakemore WE, Stuart DI, King AM, (1999) Evidence for the role of His-142 of protein 1C in the acid-induced disassembly of foot-and-mouth disease virus capsids. J Gen Virol 80: 1911-1918.
14. Mateo R, Díaz A, Baranowski E, Mateu MG, (2003) Complete alanine scanning of intersubunit interfaces in a foot-and-mouth disease virus capsid reveals critical contributions of many side chains to particle stability and viral function. J Biol Chem 278: 41019-41027.
15. Van Rensburg HG, Henry T, Mason PW, (2004) Studies of genetically defined chimeras of a European type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus. J Gen Virol 85: 61-68.
16. Maree FF, Blignaut B, de Beer TAP, Visser N, Rieder E, (2010) Mapping of amino acid residues responsible for adhesion of cell culture-adapted foot-and-mouth disease SAT type viruses. Virus Res 153: 82-91.
17. Liljas L, (1986) The structure of spherical viruses. Prog Biophys Mol Biol 48: 1-36.
18. Rossmann MG, Johnson JE, (1989) Icosahedral RNA virus structure. Annu Rev Biochem 58: 533-573.
19. Reguera J, Carreira A, Riolobos L, Almendral JM, Mateu MG, (2004) Role of interfacial amino acid residues in assembly, stability, and conformation of a spherical virus capsid. Proc Natl Acad Sci USA 101: 2724-2729.
20. Reguera J, Grueso E, Carreira A, Sánchez-Martínez C, Almendral JM, et al. (2005) Functional relevance of amino acid residues involved in interactions with ordered nucleic acid in a spherical virus. J Biol Chem 280: 17969-77.
21. Mateo R, Luna E, Rincón V, Mateu MG, (2008) Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines. J Virol 82: 12232-40.
22. Vosloo W, Kirkbride E, Bengis RG, Keet DF, Thomson GR, (1995) Genome variation in the SAT types of foot-and-mouth disease viruses prevalent in buffalo (Syncerus caffer) in the Kruger National Park and other regions of southern Africa, 1986-93. Epidemiol Infect 114: 203-218.
23. Van Rensburg HG, Nel LH, (1999) Characterization of the structural-protein-coding region SAT 2 type foot-and-mouth disease virus. Virus Genes 19: 229-233.
24. Bastos ADS, Haydon DT, Forsberg R, Knowles NJ, Anderson EC, et al. (2001) Genetic heterogeneity of SAT-1 type foot-an-d-mouth disease viruses in southern Africa. Arch Virol 146: 1537-1551.
25. Bastos ADS, Haydon DT, Sangare O, Boshoff CI, Edrich JL, et al. (2003) The implications of virus diversity within the SAT 2 serotype for control of foot-and-mouth disease in sub-Saharan Africa. J Gen Virol 84: 1595-1606.
26. Mateu MG, (1995) Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res 38: 1-24.
27. Mateu MG, Valero ML, Andreu D, Domingo E, (1996) Systematic replacement of amino acid residues within an Arg-Gly-Asp-containing loop of foot-and-mouth disease virus and effect on cell recognition. J Biol Chem 271: 12814-12819.
28. Samuel AR, Knowles NJ, (2001) Foot-and-mouth disease virus: cause of the recent crisis for the UK livestock industry. Trends Genet 17: 421-424.
29. Rossmann MG, Greve JM, Kolatkar PR, Olson NH, Smith TJ, et al. (1997) in Structural Biology of Viruses (Chiu W, Garcea R, Burnette R, eds). 105-133, Oxford University, Press, Oxford.
30. Brown F, (1963) Cartwright (1963) Purification of radioactive foot-and-mouth disease virus. Nature 199: 1168-70.
31. Burroughs JN, Rowlands DJ, Sangar DV, Talbot P, Brown F, (1971) Further evidence for multiple proteins in the foot-and-mouth disease virus particle. J Gen Virol 13: 73-84.
32. Carrillo EC, Giachetti C, Campos RH, (1984) Effect of lysosomotropic agents on the foot-and-mouth disease virus replication. Virology 135: 542-545.
33. Curry S, Fry E, Blakemore W, Abu-Ghazaleh R, Jackson T, et al. (1997) Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J Virol 71: 9743-9752.
34. Van Vlijmen HWT, Curry S, Schaefer M, Karplus M, (1998) Titration calculations of foot-and-mouth disease virus capsid and their stabilities as a function of pH. J Mol Biol 275: 295-308.
35. Rieder E, Bunch T, Brown F, Mason PW, (1993) Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J Virol 67: 5139-5145.
36. Duque H, Baxt B, (2003) FMDV receptors: comparison of bovine αv integrin utilization by type A and O Viruses. J Virol 77: 2500-2511.
37. Duque H, LaRocco M, Golde WT, Baxt B, (2004) Interactions of foot-and-mouth disease virus with soluble bovine αVβ3 and αVβ6 integrins. J Virol 78: 9773-81.
38. Office International des Epizooties (2009). In Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2009, Chapter 2.1.5. 1-25. Office International des Epizooties, Paris, France.
39. Rweyemamu MM, Ouldridge EJ, Head M, Ferrari R, (1984) The effect of antiserum quality on strain specificity assessment of foot and mouth disease virus by the neutralization reaction. J Biol Stand 12: 295-303.
40. Doel TR, Mowat GN, (1985) An international collaborative study on foot and mouth disease virus assay methods. 2. Quantification of 146S particles. J Biol Stand 13: 335-44.
41. Knipe T, Rieder E, Baxt B, Ward G, Mason P, (1997) Characterization of synthetic foot-and-mouth disease virus provirions separates acid-mediated disassembly from infectivity. J Virol 71: 2851-2856.
42. Mateo R, Mateu MG, (2007) Deterministic, compensatory mutational events in the capsid of foot-and-mouth disease virus in response to the introduction of mutations found in viruses from persistent infections. J Virol 81: 1879-87.
43. Mateo R, Luna E, Mateu MG, (2007) Thermostable variants are not generally represented in foot-and-mouth disease virus quasispecies. J Gen Virol 88: 859-864.
44. R Development Core Team (2009) R: A Language and Environment for Statistical Computing.
45. Logan D, Abu-Ghazaleh R, Blakemore W, Curry S, Jackson T, et al. (1993) Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 362: 566-568.
46. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG, (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25: 4876-82.
47. Fiser A, Sali A, (2003) Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol 374: 461-491.
48. Li H, Robertson AD, Jensen JH, (2005) Very fast empirical prediction and rationalization of protein pKa values. Proteins 61: 704-721.
49. Krieger E, Nielsen JE, Spronk CA, Vriend G, (2006) Fast empirical pKa prediction by Ewald summation. J Mol Graph Model 25: 481-486.
50. Burman A, Clark S, Abrescia NG, Fry EE, Stuart DI, et al. (2006) Specificity of the VP1 GH Loop of foot-and-mouth disease virus for αv integrins. J Virol 80: 9798-9810.
51. Jackson T, Clarck SJ, Berryman S, Burman A, Cambier S, et al. (2004) Integrin αvβ8 functions as a receptor for foot-and-mouth disease virus: Role of the β-chain cytodomain in integrin-mediated infection. J Virol 78: 4533-4540.
52. Jackson T, Mould AP, Sheppard D, King AMQ, (2002) Integrin αvβ1 is a receptor for foot-and-mouth disease virus. J Virol 76: 935-941.
53. Neff S, Mason PW, Baxt B, (2000) High-efficiency utilization of the bovine integrin αvβ3 as a receptor for foot-and-mouth disease virus is dependent on the bovine β3 subunit. J Virol 74: 7298-7306.
54. Boettiger D, Lynch L, Blystone S, Huber F, (2001) Distinct ligand-binding modes for integrin αvβ3-mediated adhesion to fibronectin versus vitronectin. J Biol Chem 276: 31684-90.
55. Lea S, Hernandez J, Blakemore W, Brocchi E, Curry S, et al. (1994) The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2: 123-139.
56. Lea S, Abu-Ghazaleh R, Blakemore W, Curry S, Fry E, et al. (1995) Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant G67. Structure 3: 571-580.
57. Twomey T, France LL, Hassard S, Burrage TG, Newman JFE, et al. (1995) Characterization of an acid-resistant mutant of foot-and-mouth disease virus. Virology 206: 69-75.
58. Curry S, Abrams CC, FryE, Crowther JC, Belsham GJ, et al. (1995) Viral RNA modulates the acid sensitivity of Foot-and-mouth disease virus capsids. J Virol 69: 430-438.